Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Qualys
QLYS
$6.29B
| $2.13M | ﹤0.01% |
18,950
+1,673
| +10% | +$209K |
|
|
BSX.PRA
2177
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
| $2.13M | ﹤0.01% |
18,522
+10,900
| +143% | +$1.2M |
|
2178
CALL
Bloom Energy
BE
$63.6B
| $2.13M | ﹤0.01% |
+111,200
| New | +$2.18M |
|
2179
National Bank Holdings
NBHC
$1.91B
| $2.13M | ﹤0.01% |
50,530
+31,169
| +161% | +$1.35M |
|
2180
Valmont Industries
VMI
$9.59B
| $2.12M | ﹤0.01% |
6,420
-2,399
| -27% | -$761K |
|
2181
Inovio Pharmaceuticals
INO
$67.4M
| $2.11M | ﹤0.01% |
112,801
+16,428
| +17% | +$372K |
|
2182
Frontdoor
FTDR
$6.46B
| $2.1M | ﹤0.01% |
101,041
+19,841
| +24% | +$436K |
|
2183
Avnet
AVT
$7.93B
| $2.1M | ﹤0.01% |
50,418
-37,200
| -42% | -$1.55M |
|
|
GES
2184
PUT
DELISTED
Guess Inc
GES
| $2.09M | ﹤0.01% |
+101,200
| New | +$1.86M |
|
|
SFBS
2185
ServisFirst Bancshares
SFBS
$4.86B
| $2.09M | ﹤0.01% |
30,320
+6,025
| +25% | +$450K |
|
2186
Commerce Bancshares
CBSH
$8.5B
| $2.09M | ﹤0.01% |
35,524
-1,395
| -4% | -$81.3K |
|
2187
PagerDuty
PD
$898M
| $2.08M | ﹤0.01% |
78,387
-26,031
| -25% | -$615K |
|
2188
CALL
Sea Limited
SE
$69.1B
| $2.08M | ﹤0.01% |
+40,000
| New | +$2.16M |
|
2189
Cogent Biosciences
COGT
$7.22B
| $2.07M | ﹤0.01% |
179,492
+31,236
| +21% | +$387K |
|
2190
GDS Holdings
GDS
$6.41B
| $2.07M | ﹤0.01% |
100,578
+15,892
| +19% | +$243K |
|
2191
Option Care Health
OPCH
$3.6B
| $2.07M | ﹤0.01% |
68,843
+43,858
| +176% | +$1.36M |
|
|
CMPS
2192
Compass Pathways
CMPS
$1.82B
| $2.07M | ﹤0.01% |
257,437
| – | – |
|
|
SRNE
2193
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $2.07M | ﹤0.01% |
2,332,719
+337,068
| +17% | +$447K |
|
2194
Green Plains
GPRE
$1.01B
| $2.07M | ﹤0.01% |
67,761
-42,077
| -38% | -$1.3M |
|
2195
Carter's
CRI
$1.47B
| $2.07M | ﹤0.01% |
27,694
+2,291
| +9% | +$164K |
|
2196
FB Financial Corp
FBK
$3.05B
| $2.06M | ﹤0.01% |
57,117
+2,487
| +5% | +$99.6K |
|
|
UHT
2197
Universal Health Realty Income Trust
UHT
$593M
| $2.06M | ﹤0.01% |
43,194
+4,621
| +12% | +$223K |
|
|
B
2198
CALL
Barrick Mining
B
$73.2B
| $2.06M | ﹤0.01% |
+120,000
| New | +$1.91M |
|
2199
Academy Sports + Outdoors
ASO
$2.96B
| $2.06M | ﹤0.01% |
39,214
-249,373
| -86% | -$11.9M |
|
2200
Century Communities
CCS
$2.04B
| $2.06M | ﹤0.01% |
41,182
+12,132
| +42% | +$574K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.